High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience

High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience

Aim. To assess the long-term results of high-dose chemotherapy following autologous hematopoietic stem cell transplantation (autoHSCT) for multiple myeloma (MM) in the real setting and influence of different factors on the results. Materials and methods. From 2006 till 2018 in Pirogovs Center wer...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Nikita E. Mochkin, Vladislav O. Sarzhevskiy, Julia N. Dubinina, Elena G. Smirnova, Denis A. Fedorenko, Anna E. Bannikova, Dina S. Kolesnikova, Vladimir S. Bogatyrev, Anastasia A. Samoylova, Nikolay M. Faddeev, Vladimir Ya. Melnichenko
Format: article
Langue:RU
Publié: IP Habib O.N. 2020
Sujets:
multiple myeloma
high-dose chemotherapy
autologous hematopoietic stem cell transplantation
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Accès en ligne:https://doaj.org/article/71812a52bfeb4a50a069644ca48f8b9e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/71812a52bfeb4a50a069644ca48f8b9e

Documents similaires